AMINA BOUDAIA: Open Payments
NPI 1912736638 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$67 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $67
Food & beverage: $67
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| GENZYME CORPORATION | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| BioCryst US Sales Co., LLC | 1 | $16 |
Products named: BREZTRI, Xolair, ORLADEYO.
Industry payments across IN — which companies pay providers there.
